文献速递产科母胎医学

重新审视胎盘与脐带植入异常的产前筛查

Rethinking Prenatal Screening for Anomalies of Placental and Umbilical Cord Implantation.
PubMed 文献 · Obstet Gynecol · 2020-01-01

本文综述胎盘与脐带植入异常(前置胎盘、胎盘植入谱系、血管前置)的产前筛查现状与挑战。产前诊断可改善围产结局且超声诊断效能被认 为优异,但胎盘植入谱系与血管前置的患病率及超声敏感性特异性因缺乏组织病理确认而难以评估。近期流行病学研究显示这些异常发生率上升,可能与辅助生殖技术及剖宫产使用增加有关。

要点

  • 前置胎盘应在孕中期常规详细胎儿解剖超声中评估胎盘位置。
  • 胎盘植入谱系与血管前置的筛查诊断应整合入产科超声培训项目。
  • 高危孕妇应采纳标准化的靶向筛查方案。

核心结论

  • 产前诊断胎盘与脐带植入异常可改善围产结局,应将胎盘植入谱系和血管前置的筛查诊断整合入产科超声培训。

研究设计与样本

  • 本文为综述,检索范围涉及胎盘与脐带植入异常的产前筛查相关流行病学与超声诊断证据。

主要发现

  • 有中等质量证据表明产前诊断这些异常可改善围产结局,超声诊断性能被认为优异。
  • 前置胎盘流行病学已知,常规孕中期详细胎儿解剖超声评估胎盘位置是标准临床实践。
  • 胎盘植入谱系与血管前置的患病率因多数研究缺乏详细组织病理确认数据而难以评估。
  • 近期流行病学研究显示胎盘与脐带植入异常发生率上升,可能与辅助生殖技术和剖宫产使用增加有关。

关键数值与推荐

  • 有良好证据支持对高危孕妇采用靶向标准化方案。
  • 胎盘植入谱系和血管前置的筛查与诊断应整合入产科超声培训项目。

临床怎么用

  • 孕中期常规详细胎儿解剖超声应评估胎盘位置以筛查前置胎盘。
  • 对高危孕妇应实施靶向标准化超声筛查方案。
  • 产科超声培训应纳入胎盘植入谱系与血管前置的筛查诊断内容。

局限性

  • 多数研究缺乏详细组织病理确认数据,胎盘植入谱系与血管前置的患病率难以评估。
  • 超声诊断这些异常的敏感性和特异性也因同样原因难以评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The most common anomalies of implantation of the placenta and umbilical cord include placenta previa, placenta accreta spectrum, and vasa previa, and are associated with considerable perinatal and maternal morbidity and mortality. There is moderate quality evidence that prenatal diagnosis of these conditions improves perinatal outcomes and the performance of ultrasound imaging in diagnosing them is considered excellent. The epidemiology of placenta previa is well known, and it is standard clinical practice to assess placental location at the routine screening second-trimester detailed fetal anatomy ultrasound examination. In contrast, the prevalence of placenta accreta spectrum and vasa previa in the general population is more difficult to evaluate because detailed confirmatory histopathologic data are not available in most studies. The sensitivity and specificity of ultrasonography for the diagnosis of these anomalies is also difficult to assess. Recent epidemiologic studies show an increase in the incidence of placental and umbilical cord implantation anomalies, which may be the result of increased use of assisted reproductive technology and cesarean delivery. There is good evidence to support targeted standardized protocols for women at high risk and that screening and diagnosing placenta accreta spectrum and vasa previa should be integrated into obstetric ultrasound training programs.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Jauniaux E, Silver RM. Rethinking Prenatal Screening for Anomalies of Placental and Umbilical Cord Implantation. Obstet Gynecol. 2020. PMID: 33156190. doi:10.1097/AOG.0000000000004175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。